UNLIMITED FREE ACCESS TO THE WORLD'S BEST IDEAS

close
Already an Engineering360 user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your Engineering360 Experience

close
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

NAVY - BUMED 6300.21A

(BUMED-M3) HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS MANAGEMENT PROGRAM

active, Most Current
Organization: NAVY
Publication Date: 31 December 2018
Status: active
Page Count: 15
scope:

Scope and Applicability.

This instruction applies to all medical centers, dental centers, hospitals, clinics, and tenant commands using tissue. This instruction does not reflect the process for retrieving living organ donations or vascularized composite allografts for transplantation. Refer to reference (a) for retrieving living organ donations or vascularized composite allografts for transplantation. References (b), part 1270 and part 1271, through (f) amplify regulatory requirements for management of HCT/Ps. Accreditation requirements for management of HCT/Ps can be found in reference (f), the American Association of Blood Banks (AABB) Guidelines for Managing Tissue Allografts in Hospitals, American Association for Tissue Banking Standards for Tissue Banking and the Standards of the College of American Pathologists.

Document History

BUMED 6300.21A
December 31, 2018
(BUMED-M3) HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS MANAGEMENT PROGRAM
Scope and Applicability. This instruction applies to all medical centers, dental centers, hospitals, clinics, and tenant commands using tissue. This instruction does not reflect the process for...

References

Advertisement